GOLT1B
gene geneOn this page
Also known as CGI-141YMR292WGOT1
Summary
GOLT1B (golgi transport 1B, HGNC:20175) is a protein-coding gene on chromosome 12p12.1, encoding Vesicle transport protein GOT1B (Q9Y3E0). May be involved in fusion of ER-derived transport vesicles with the Golgi complex.
Involved in positive regulation of canonical NF-kappaB signal transduction. Located in endoplasmic reticulum. Part of protein-containing complex.
Source: NCBI Gene 51026 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 24 total
- Druggable target: yes
- MANE Select transcript:
NM_016072
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20175 |
| Approved symbol | GOLT1B |
| Name | golgi transport 1B |
| Location | 12p12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CGI-141, YMR292W, GOT1 |
| Ensembl gene | ENSG00000111711 |
| Ensembl biotype | protein_coding |
| OMIM | 615078 |
| Entrez | 51026 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 4 protein_coding, 3 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000229314, ENST00000535593, ENST00000539025, ENST00000539663, ENST00000540141, ENST00000542038, ENST00000542194, ENST00000545093, ENST00000545113, ENST00000631252
RefSeq mRNA: 1 — MANE Select: NM_016072
NM_016072
CCDS: CCDS8689
Canonical transcript exons
ENST00000229314 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000994911 | 21515669 | 21518408 |
| ENSE00003486969 | 21508383 | 21508561 |
| ENSE00003633372 | 21506885 | 21506976 |
| ENSE00003639140 | 21512295 | 21512376 |
| ENSE00003841751 | 21501789 | 21501948 |
Expression profiles
Bgee: expression breadth ubiquitous, 284 present calls, max score 99.14.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 47.7259 / max 1063.6702, expressed in 1819 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 124666 | 41.3772 | 1816 |
| 124668 | 3.3284 | 1314 |
| 124667 | 2.2830 | 1176 |
| 124669 | 0.7373 | 398 |
Top tissues by expression
292 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 99.14 | gold quality |
| oocyte | CL:0000023 | 97.51 | gold quality |
| tibia | UBERON:0000979 | 96.86 | gold quality |
| islet of Langerhans | UBERON:0000006 | 94.82 | gold quality |
| endothelial cell | CL:0000115 | 94.80 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 94.55 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 94.54 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 94.42 | gold quality |
| cartilage tissue | UBERON:0002418 | 94.41 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 94.15 | gold quality |
| synovial joint | UBERON:0002217 | 94.10 | gold quality |
| eye | UBERON:0000970 | 94.04 | gold quality |
| calcaneal tendon | UBERON:0003701 | 93.91 | gold quality |
| stromal cell of endometrium | CL:0002255 | 93.73 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 93.47 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 93.28 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 93.16 | gold quality |
| parietal pleura | UBERON:0002400 | 93.12 | gold quality |
| superficial temporal artery | UBERON:0001614 | 93.05 | gold quality |
| pericardium | UBERON:0002407 | 92.85 | gold quality |
| body of pancreas | UBERON:0001150 | 92.79 | gold quality |
| pancreas | UBERON:0001264 | 92.78 | gold quality |
| endometrium | UBERON:0001295 | 92.76 | gold quality |
| visceral pleura | UBERON:0002401 | 92.68 | gold quality |
| decidua | UBERON:0002450 | 92.66 | gold quality |
| skin of hip | UBERON:0001554 | 92.61 | gold quality |
| placenta | UBERON:0001987 | 92.61 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 92.59 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 92.56 | gold quality |
| pons | UBERON:0000988 | 92.38 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7249 | no | 1578.95 |
| E-MTAB-7303 | no | 46.32 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
199 targeting GOLT1B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-499A-5P | 99.98 | 70.79 | 1323 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-3617-3P | 99.98 | 67.86 | 918 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
Cross-species orthologs
28 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | golt1ba | ENSDARG00000022795 |
| danio_rerio | golt1bb | ENSDARG00000059308 |
| mus_musculus | Golt1b | ENSMUSG00000030245 |
| rattus_norvegicus | Golt1b | ENSRNOG00000058386 |
| drosophila_melanogaster | CG32576 | FBGN0052576 |
| caenorhabditis_elegans | WBGENE00007112 | |
| caenorhabditis_elegans | WBGENE00008042 | |
| caenorhabditis_elegans | WBGENE00008043 | |
| caenorhabditis_elegans | WBGENE00008044 | |
| caenorhabditis_elegans | WBGENE00009237 | |
| caenorhabditis_elegans | WBGENE00013035 | |
| caenorhabditis_elegans | WBGENE00013037 | |
| caenorhabditis_elegans | WBGENE00013044 | |
| caenorhabditis_elegans | WBGENE00013101 | |
| caenorhabditis_elegans | WBGENE00013949 | |
| caenorhabditis_elegans | WBGENE00013950 | |
| caenorhabditis_elegans | WBGENE00015775 | |
| caenorhabditis_elegans | WBGENE00017764 | |
| caenorhabditis_elegans | WBGENE00019029 | |
| caenorhabditis_elegans | WBGENE00019269 | |
| caenorhabditis_elegans | WBGENE00019368 | |
| caenorhabditis_elegans | WBGENE00020341 | |
| caenorhabditis_elegans | WBGENE00020393 | |
| caenorhabditis_elegans | WBGENE00020662 | |
| caenorhabditis_elegans | WBGENE00021601 | |
| caenorhabditis_elegans | Y110A7A.7 | WBGENE00022457 |
| caenorhabditis_elegans | WBGENE00044488 | |
| caenorhabditis_elegans | WBGENE00189950 |
Paralogs (3): DAGLA (ENSG00000134780), DAGLB (ENSG00000164535), GOLT1A (ENSG00000174567)
Protein
Protein identifiers
Vesicle transport protein GOT1B — Q9Y3E0 (reviewed: Q9Y3E0)
Alternative names: Germ cell tumor 2, Golgi transport 1 homolog B, Putative NF-kappa-B-activating protein 470, hGOT1a
All UniProt accessions (5): Q9Y3E0, F5GWD8, F5GXH6, F5H6U7, G3V1U5
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in fusion of ER-derived transport vesicles with the Golgi complex.
Subcellular location. Golgi apparatus membrane.
Tissue specificity. Widely expressed. Tends to be up-regulated in seminomas compared to normal testis.
Similarity. Belongs to the GOT1 family.
RefSeq proteins (1): NP_057156* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007305 | Vesicle_transpt_Got1/SFT2 | Family |
| IPR045176 | Got1 | Family |
Pfam: PF04178
UniProt features (13 total): topological domain 5, transmembrane region 4, sequence conflict 2, chain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y3E0-F1 | 88.17 | 0.54 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 1
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 528 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN, MODULE_52, GOBP_MEMBRANE_DEPOLARIZATION, GOBP_RESPONSE_TO_NITROGEN_COMPOUND, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS, MULLIGHAN_NPM1_SIGNATURE_3_UP, GOBP_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, GOBP_RESPONSE_TO_IMMOBILIZATION_STRESS, GOBP_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS, GOBP_RESPONSE_TO_CORTICOSTEROID, TTTGTAG_MIR520D, GOBP_ALPHA_AMINO_ACID_METABOLIC_PROCESS, KEGG_CYSTEINE_AND_METHIONINE_METABOLISM
GO Biological Process (5): endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888), protein transport (GO:0015031), retrograde transport, endosome to Golgi (GO:0042147), positive regulation of canonical NF-kappaB signal transduction (GO:0043123), vesicle-mediated transport (GO:0016192)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (8): Golgi membrane (GO:0000139), endoplasmic reticulum (GO:0005783), cytosol (GO:0005829), membrane (GO:0016020), protein-containing complex (GO:0032991), cytoplasm (GO:0005737), Golgi apparatus (GO:0005794), endomembrane system (GO:0012505)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 4 |
| cellular anatomical structure | 4 |
| intercellular transport | 2 |
| transport | 2 |
| endomembrane system | 2 |
| intracellular membrane-bounded organelle | 2 |
| intracellular transport | 1 |
| Golgi vesicle transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| endosomal transport | 1 |
| cytosolic transport | 1 |
| canonical NF-kappaB signal transduction | 1 |
| regulation of canonical NF-kappaB signal transduction | 1 |
| positive regulation of intracellular signal transduction | 1 |
| cellular process | 1 |
| binding | 1 |
| Golgi apparatus | 1 |
| bounding membrane of organelle | 1 |
| cellular_component | 1 |
| intracellular anatomical structure | 1 |
| vacuole | 1 |
| plasma membrane | 1 |
Protein interactions and networks
STRING
2324 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GOLT1B | INTS13 | Q9NVM9 | 720 |
| GOLT1B | SPRYD3 | Q8NCJ5 | 494 |
| GOLT1B | SERTAD4 | Q9NUC0 | 488 |
| GOLT1B | PYROXD1 | Q8WU10 | 469 |
| GOLT1B | GTPBP10 | A4D1E9 | 452 |
| GOLT1B | GOLM2 | Q6P4E1 | 442 |
| GOLT1B | GYS2 | P54840 | 426 |
| GOLT1B | SLC30A1 | Q9Y6M5 | 394 |
| GOLT1B | OSER1 | Q9NX31 | 385 |
| GOLT1B | MANF | P55145 | 381 |
| GOLT1B | GPANK1 | O95872 | 379 |
| GOLT1B | RCOR3 | Q9P2K3 | 378 |
| GOLT1B | TMED2 | Q15363 | 370 |
| GOLT1B | KCNJ8 | Q15842 | 360 |
| GOLT1B | PLEKHA5 | Q9HAU0 | 359 |
IntAct
63 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GOLT1B | SH3GL3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SDCBP | GOLT1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPG21 | GOLT1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| INPP5K | GOLT1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SHISAL2A | GOLT1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAR1A | GOLT1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| GPR152 | GOLT1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SH3GL3 | GOLT1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| MUC1 | GOLT1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| CREB3L1 | GOLT1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC10A6 | GOLT1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM30B | KLRG2 | psi-mi:“MI:0914”(association) | 0.530 |
| GOLT1B | psi-mi:“MI:0915”(physical association) | 0.400 | |
| Tmem109 | ASXL2 | psi-mi:“MI:0914”(association) | 0.350 |
| Uso1 | SLC30A6 | psi-mi:“MI:0914”(association) | 0.350 |
| REEP5 | CNOT1 | psi-mi:“MI:0914”(association) | 0.350 |
| NABP1 | XPO1 | psi-mi:“MI:0914”(association) | 0.350 |
| KATNA1 | KATNBL1 | psi-mi:“MI:0914”(association) | 0.350 |
| GOLT1B | psi-mi:“MI:0914”(association) | 0.350 | |
| ESYT2 | psi-mi:“MI:0914”(association) | 0.350 | |
| E5 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| ORF28 | PEX19 | psi-mi:“MI:0914”(association) | 0.350 |
| OCRL | MYO1C | psi-mi:“MI:0914”(association) | 0.350 |
| RAC1 | psi-mi:“MI:0914”(association) | 0.350 | |
| HLA-C | psi-mi:“MI:0914”(association) | 0.350 | |
| GOLT1B | NBAS | psi-mi:“MI:0914”(association) | 0.350 |
| BSCL2 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (260): GOLT1B (Affinity Capture-MS), GOLT1B (Proximity Label-MS), GOLT1B (Proximity Label-MS), ANXA1 (Affinity Capture-MS), ATP1A1 (Affinity Capture-MS), ATP2A2 (Affinity Capture-MS), ATP5A1 (Affinity Capture-MS), ATP5B (Affinity Capture-MS), ATP5J (Affinity Capture-MS), ATP6V1A (Affinity Capture-MS), ATP6V1B2 (Affinity Capture-MS), ATP6V1E1 (Affinity Capture-MS), ATP6V0A1 (Affinity Capture-MS), ATP6AP1 (Affinity Capture-MS), ATP5O (Affinity Capture-MS)
ESM2 similar proteins: A1CKG4, A3LPS1, A4R2N5, A5DEQ7, A5DSM9, A6QRX6, A6RRF7, A6ZMD0, A7EMV1, A7S6Y0, A7TS55, B2AR67, B3M9W1, B3NDM7, B4GRI8, B4HIJ8, B4J043, B4L0H1, B4LIH0, B4MXW6, B4PD01, B4QLP9, O74375, O95562, Q03554, Q04767, Q0CNZ5, Q0V0G4, Q1E1E0, Q20263, Q2NKV8, Q2YDE3, Q4FZV2, Q54CL4, Q5APC0, Q5SSN7, Q5U3Y5, Q60EA5, Q6BWE7, Q6CC06
Diamond homologs: Q03554, Q20263, Q2NKV8, Q2YDE3, Q54CL4, Q6NMM1, Q6ZVE7, Q9CR60, Q9DCQ3, Q9USJ2, Q9Y3E0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 9 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1953 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:99397682:CTTGG:C | acceptor_gain | 1.0000 |
| 10:99397687:C:CC | acceptor_gain | 1.0000 |
| 10:99397690:T:C | acceptor_gain | 1.0000 |
| 10:99397690:T:TC | acceptor_gain | 1.0000 |
| 10:99397698:C:CT | acceptor_gain | 1.0000 |
| 10:99402578:A:AC | donor_gain | 1.0000 |
| 10:99402579:C:CC | donor_gain | 1.0000 |
| 10:99402721:TC:T | acceptor_gain | 1.0000 |
| 10:99402722:CC:C | acceptor_gain | 1.0000 |
| 10:99403472:T:A | donor_gain | 1.0000 |
| 10:99403520:C:CA | donor_gain | 1.0000 |
| 10:99403635:C:CC | acceptor_gain | 1.0000 |
| 10:99403722:A:AC | donor_gain | 1.0000 |
| 10:99403723:C:CC | donor_gain | 1.0000 |
| 10:99405752:TTA:T | donor_loss | 1.0000 |
| 10:99405755:C:CA | donor_loss | 1.0000 |
| 10:99405861:C:CC | acceptor_gain | 1.0000 |
| 10:99406132:CCCA:C | donor_loss | 1.0000 |
| 10:99406133:CCA:C | donor_loss | 1.0000 |
| 10:99406134:CA:C | donor_loss | 1.0000 |
| 10:99406135:A:C | donor_loss | 1.0000 |
| 10:99406136:C:CA | donor_loss | 1.0000 |
| 10:99406220:C:CT | acceptor_gain | 1.0000 |
| 10:99406221:A:T | acceptor_gain | 1.0000 |
| 10:99406246:TTCT:T | acceptor_gain | 1.0000 |
| 10:99406248:CT:C | acceptor_gain | 1.0000 |
| 10:99406250:C:CC | acceptor_gain | 1.0000 |
| 10:99406251:T:G | acceptor_loss | 1.0000 |
| 10:99406254:A:AC | acceptor_gain | 1.0000 |
| 10:99406254:A:C | acceptor_gain | 1.0000 |
AlphaMissense
905 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:21506905:G:A | G16R | 0.999 |
| 12:21506905:G:C | G16R | 0.999 |
| 12:21506912:G:A | G18E | 0.999 |
| 12:21506972:G:T | G38V | 0.999 |
| 12:21506906:G:A | G16E | 0.998 |
| 12:21506911:G:A | G18R | 0.998 |
| 12:21506911:G:C | G18R | 0.998 |
| 12:21506933:G:A | G25E | 0.998 |
| 12:21506971:G:A | G38R | 0.998 |
| 12:21506971:G:C | G38R | 0.998 |
| 12:21506972:G:A | G38E | 0.998 |
| 12:21506976:T:A | N39K | 0.998 |
| 12:21506976:T:G | N39K | 0.998 |
| 12:21508398:G:C | G45R | 0.998 |
| 12:21508521:G:C | G86R | 0.998 |
| 12:21508522:G:A | G86D | 0.998 |
| 12:21508543:G:A | G93E | 0.998 |
| 12:21506890:G:A | G11R | 0.997 |
| 12:21506890:G:C | G11R | 0.997 |
| 12:21506896:G:A | G13R | 0.997 |
| 12:21506896:G:C | G13R | 0.997 |
| 12:21506932:G:A | G25R | 0.997 |
| 12:21506932:G:C | G25R | 0.997 |
| 12:21506933:G:T | G25V | 0.997 |
| 12:21508399:G:A | G45D | 0.997 |
| 12:21508485:G:C | G74R | 0.997 |
| 12:21508542:G:A | G93R | 0.997 |
| 12:21508542:G:C | G93R | 0.997 |
| 12:21512299:T:C | F101L | 0.997 |
| 12:21512301:C:A | F101L | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000209483 (12:21511986 T>A), RS1000300399 (12:21510608 T>G), RS1000575319 (12:21499900 C>A), RS1000678648 (12:21518512 A>G), RS1000728860 (12:21511676 G>A), RS1001418717 (12:21510191 T>C), RS1001441652 (12:21508834 A>G), RS1001607032 (12:21502757 T>C), RS1001647251 (12:21515901 TAAG>T), RS1001973375 (12:21516133 A>G), RS1002319432 (12:21504836 A>T), RS1002421610 (12:21511432 A>C), RS1002446117 (12:21507046 C>T), RS1002653414 (12:21516197 A>G,T), RS1002876081 (12:21504105 A>C)
Disease associations
OMIM: gene MIM:615078 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6066348 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 7.01 | Kd | 96.96 | nM | CHEMBL5653589 |
| 7.01 | ED50 | 96.96 | nM | CHEMBL5653589 |
PubChem BioAssay actives
1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2148450: Binding affinity to human GOLT1B incubated for 45 mins by Kinobead based pull down assay | kd | 0.0970 | uM |
CTD chemical–gene interactions
50 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, increases expression | 3 |
| Cyclosporine | increases expression | 3 |
| bisphenol A | decreases expression, decreases methylation | 2 |
| sodium arsenite | increases abundance, increases expression | 2 |
| Air Pollutants | affects cotreatment, increases abundance, increases oxidation, decreases expression | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | increases expression | 1 |
| bisphenol F | increases expression | 1 |
| dicrotophos | decreases expression | 1 |
| methylmercuric chloride | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| alpha-pinene | increases oxidation, increases abundance, affects cotreatment | 1 |
| decabromobiphenyl ether | increases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| arsenite | increases reaction, affects binding | 1 |
| methylparaben | increases expression | 1 |
| tetrabromobisphenol A | increases expression | 1 |
| ochratoxin A | affects cotreatment, increases expression | 1 |
| methacrylaldehyde | affects cotreatment, increases oxidation, increases abundance | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| K 7174 | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| bisphenol B | increases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | increases expression | 1 |
| hexabrominated diphenyl ether 153 | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| picoxystrobin | increases expression | 1 |
| NSC 689534 | affects binding, increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5651492 | Binding | Binding affinity to human GOLT1B incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D7QT | Ubigene A-549 GOLT1B KO | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.